Corneal Transplant Research Report
The Global Corneal Transplant Market reached US$ 523.88 million in 2024 and is expected to reach US$ 1,006.95 billion by 2033, growing at a CAGR of 7.59% during the forecast period 2025-2033.
A corneal transplant is a surgical procedure in which a damaged or diseased cornea, the clear outer layer of the eye, is replaced with a healthy donor cornea. This procedure, also known as keratoplasty, aims to restore vision in individuals suffering from conditions like corneal blindness, scarring, or infection.
The transplant can be partial (replacing only the damaged layer of the cornea) or full (replacing the entire cornea), depending on the severity of the condition. With advancements in surgical techniques and better donor cornea availability, corneal transplants have a high success rate, significantly improving the quality of life for many patients. As the global incidence of eye disorders rises, the demand for corneal transplants continues to grow, offering hope for better vision and brighter futures.
Download Free Sample PDF: https://www.datamintelligence.com/download-sample/corneal-transplant-market
Market Growth Drivers:
Growing number of corneal diseases and eye disorders
The increasing prevalence of corneal diseases and eye disorders is a key factor driving the demand for corneal transplants. Conditions like keratoconus, corneal dystrophies, infections, and scarring are becoming more widespread, creating a growing need for transplants to restore vision. For example, the National Institutes of Health (NIH) reported in 2022 that keratoconus affects approximately 5% of the population in certain regions, such as the Middle East.
The rising demand for corneal transplants worldwide is being driven by several factors, prompting many institutes and clinics to perform more of these procedures. For example, over the past 35 years, LVPEI (L V Prasad Eye Institute) has successfully harvested more than 120,000 corneas, making it the largest corneal donation program in the Asia-Pacific region.
The institute now harvests over 12,000 corneas annually, significantly increasing the availability of donor corneas for transplantation. As the number of procedures continues to grow, so does the demand for the necessary devices and kits, further fueling the expansion of the market.
Complications associated with corneal transplantation
The growth of the corneal transplant market may be hindered by the complications and risks associated with the procedure, which could discourage both patients and healthcare professionals. While corneal transplants are generally successful, there are still potential issues such as graft rejection, infections, and corneal swelling, all of which could lead to transplant failure.
Market Segments:
By Procedure Type: Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artificial Corneal Transplant, Others
By Device Type: Microsurgical Instruments, Microkeratome, Optical Coherence Tomography (OCT), Artificial Corneas, Others
By Type: Human Cornea, Synthetic
By Surgery Type: Conventional Surgery, Laser-Assisted Surgery
By Indication: Fuch’s Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, Others
By End-User: Hospitals, Ophthalmic Clinics, Others
By Region: North America, Latin America, Europe, Asia Pacific, Middle East and Africa
Competitive Landscape
- Carl Zeiss AG
- CorneaGen
- Ziemer Ophthalmic Systems AG
- RUMEX International Co.
- CorNeat Vision
- KeraMed, Inc.
- Corza Ophthalmology
- Inami & CO.,Ltd
- Leica Microsystems
- Surtex Instruments Limited
Customize Your Scope: https://www.datamintelligence.com/customize/corneal-transplant-market
Regional Growth
North America is expected to hold a significant position in the global corneal transplant market share
North America is set to maintain its leadership in the global corneal transplant market due to several key factors. The region’s advanced healthcare infrastructure, strong awareness of eye health, and access to the latest medical technologies are all contributing factors. Both the United States and Canada boast well-established healthcare systems, with top-tier medical facilities and highly skilled ophthalmologists, making them leaders in performing complex corneal transplants. This expertise results in high success rates, solidifying North America as a top destination for these procedures.
Key Development
For example, a 2024 publication by the National Institutes of Health (NIH) estimates that 1.12% of individuals over 65 years old in the United States are affected by Fuchs’ Endothelial Corneal Dystrophy (FECD). This condition is more prevalent among women and the White population compared to other ethnic groups.
In addition, ongoing advancements in surgical techniques, along with innovations in artificial corneas and stem cell therapies, are further solidifying North America’s leadership in the corneal transplant market. For example, in June 2024, CorneaGen introduced Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and highly effective solution designed to improve corneal contouring for keratoconic eyes
